Breaking News, Collaborations & Alliances

Thermo Fisher, Pfizer Partner to Expand Access to NGS-Based Testing for Cancer Patients

Thermo Fisher to identify local labs that will be using its NGS technology and Pfizer will explore ways to enable affordable patient access for NGS testing.

Pfizer Inc. and Thermo Fisher Scientific Inc., entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia, where advanced genomic testing has previously been limited or unavailable. Access to local NGS testing can help to provide faster analysis of associated genes to select the right therapy for that individual patient. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters